Peptone, founded in 2018, specialises in the development of novel therapeutics against Intrinsically disordered proteins (IDP) for cancer and inflammatory diseases, to name a few. Peptone's approach stems from experimental biophysics, supercomputing, and machine learning.

Some insights

Via Vincenzo Vela 5, 6500 Bellinzona, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business